| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock, $0.0001 par value per share |
| (b) | Name of Issuer:
ENOVIX CORPORATION |
| (c) | Address of Issuer's Principal Executive Offices:
3501 W Warren Avenue, Fremont,
CALIFORNIA
, 94538. |
Item 1 Comment:
This Amendment No. 4 is being filed as an amendment to the statement on Schedule 13D relating to the Common Stock filed with the Securities and Exchange Commission ("SEC") on July 26, 2021, as amended on September 10, 2021, February 14, 2023 and July 22, 2025 (collectively, the "Statement").
Unless otherwise defined herein, capitalized terms used in this Amendment No. 4 shall have the meanings ascribed to them in the Statement. Unless amended or supplemented below, the information in the Statement remains unchanged. |
| Item 3. | Source and Amount of Funds or Other Consideration |
| | Item 3 is hereby supplemented by adding the following:
On August 8, 2025, Mr. Rodgers acquired 57,142 shares of Common Stock upon the exercise of publicly-traded warrants by the Living Trust.
On August 11, 2025, Mr. Rodgers acquired 220,114 shares of Common Stock upon the exercise of publicly-traded warrants by the Charitable Trust.
On August 28, 2025, Mr. Rodgers sold 655,255 publicly-traded warrants indirectly held by the Living Trust and the Charitable Trust.
On August 29, 2025, Mr. Rodgers sold 1,259,211 publicly-traded warrants indirectly held by the Living Trust and the Charitable Trust.
On September 18, 2025, Mr. Rodgers received 5,635 shares of Common Stock in connection with the settlement of Restricted Stock Units, and Mr. Rodgers transferred 5,635 shares of Common Stock to the Living Trust for no consideration.
On November 18, 2026, the Issuer distributed warrants to purchase Common Stock (the "Dividend Warrants") to the record holders as of November 13, 2026 (the "Record Date") of the Common Stock, at a rate of one Dividend Warrant for each four shares of Common Stock (rounded down to the nearest whole number). The Issuer also distributed Dividend Warrants to each holder of the Issuer's 3.00% Convertible Senior Notes due 2028 and 4.75% Convertible Senior Notes due 2030 (collectively, the "Convertible Notes") as of the Record Date on a pass-through basis (the "Warrant Distribution"). As a result of the Warrant Distribution, the Living Trust received Dividend Warrants to purchase 5,222,056 shares of Common Stock and the Charitable Trust received Dividend Warrants to purchase 440,228 shares of Common Stock in respect of the Convertible Notes held by the Reporting Persons. The Dividend Warrants are exercisable within 60 days of November 20, 2026. |
| Item 4. | Purpose of Transaction |
| | Reflects the aggregate number of Dividend Warrants distributed on November 18, 2026 to the Issuer's record holders of Common Stock and Convertible Notes as of November 13, 2026. |
| Item 5. | Interest in Securities of the Issuer |
| (a) | See rows (11) and (13) of the cover pages to this Amendment No. 4 for the aggregate number of shares and percentages of the shares beneficially owned by each Reporting Person. The percentages used in this Amendment No. 4 are calculated based upon 212,479,038 shares of Common Stock outstanding as of November 13, 2026 as reported in the Prospectus Supplement filed by the Issuer with the SEC on November 18, 2026. |
| (b) | See rows (7) through (10) of the cover pages to this Amendment No. 4 for the number of shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. |
| (c) | Except as described in this Amendment No. 4, the Reporting Persons have not engaged in any transactions in the Common Stock in the past sixty days. |
| (d) | To the knowledge of each of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by the Reporting Persons. |
| (e) | N/A |
| Item 7. | Material to be Filed as Exhibits. |
| | 99.1 Joint Filing Agreement dated February 14, 2023 (incorporated by reference to Exhibit 99.1 to Amendment No. 2 to the Schedule 13D filed with the SEC on February 14, 2023)
99.2 Letter Agreement, dated December 1, 2020, by and among the Issuer and its officers, directors and Initial Stockholders (incorporated by reference to Exhibit 10.1 to the Form 8-K filed by the Issuer with the SEC on December 7, 2020)
99.3 Amendment to Letter Agreement, dated July 14, 2021 by and among the Issuer and its officers, directors and Initial Stockholders (incorporated by reference to Exhibit 10.12 to the Form 8-K filed by the Issuer with the SEC on July 19, 2021)
99.4 Amended and Restated Registration Rights Agreement (incorporated by reference to Exhibit 10.10 to the Form 8-K filed by the Issuer with the SEC on July 19, 2021)
99.5 Warrant Agreement (including Form of Warrant), dated November 18, 2026, between the Issuer, Computershare Inc., a Delaware corporation, and Computershare Trust Company, N.A., as Warrant Agent (incorporated by reference to Exhibit 4.1 to the Form 8-K filed by the Issuer with the SEC on November 18, 2026) |